YEM Search

搜索结果

TRPM3

靶点ID:TCMBANKGE000213

靶点别名:GON-2; LTRPC3; MLSN2

靶点描述:transient receptor potential cation channel subfamily M member 3

染色体:9

染色体位置:9q21.12-q21.13

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:17992

OMIM_Link:608961

Ensembl_Link:ENSG00000083067

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN058948	PLO	Prestwick_859; Delta5-Pregnen-3beta-ol-20-one; C01953; Pregnenolona [INN-Spanish]; Prestwick3_000546; LMST02030088; BPBio1_000651; P9129_SIGMA; 81630_FLUKA; 3beta-Hydroxy-5-pregnene-20-one; 3beta-hydroxypregn-5-ene-20-one; Prestwick0_000546; Pregn-5-en-20-one, 3beta-hydroxy-; 5-Pregnen-3-beta-ol-20-one; Prestwick1_000546; Pregn-5-en-20-one, 3beta-hydroxy- (8CI); 3beta-Hydroxy-5-pregnen-20-one; Pregnenolone (progesterone precursor); Prestwick2_000546; Pregnenolone (JAN/INN); Spectrum5_002057; 3beta-Hydroxypregn-5-en-20-one; CMC_13393; SPBio_002512; D00143; Pregn-5-en-20-one, 3-hydroxy-, (3-beta)-; Pregnenolonum [INN-Latin]; delta5-Pregnenolone; 3beta-Hydroxy-Delta5-pregnen-20-one; BSPBio_000591; CHEBI:16581; 5-Pregnen-3beta-ol-20-one; ZINC03861150; Pregn-5-en-20-one, 3-beta-hydroxy-; 3-beta-Hydroxypregn-5-en-20-one; Pregn-5-en-3beta-ol-20-one; Delta5-Pregnene-3beta-ol-20-one; PREGNENOLONE; ST5308463; (3BETA)-3-HYDROXYPREGN-5-EN-20-ONE; 5-Pregnenolone; 17beta-[1-Ketoethyl]-Delta5-androsten-3beta-ol; EINECS 205-647-4; 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone; 145-13-1; NSC 1616; Pregn-5-ene-3beta-ol-20-one; 116907-59-6; Pregn-5-en-20-one, 3-hydroxy-, (3beta)-	C21H32O2	316.5 g/mol	CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
TCMBANKIN059724	Phenol, 2-methyl-5-(1-methylethyl)		C10H14O	150.22 g/mol	CC1=C(C=C(C=C1)C(C)C)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000002		Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Sign or Symptom	phenotype
TCMBANKDI003353		Pathological Conditions, Signs and Symptoms; Neoplasms	-	Neoplastic Process	phenotype
TCMBANKDI004191		Chemically-Induced Disorders; Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI004376		Neoplasms; Nervous System Diseases	-	Neoplastic Process	group
TCMBANKDI007832		Cardiovascular Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI009996		Eye Diseases	-	Disease or Syndrome	disease
TCMBANKDI011173		Neoplasms	-	Neoplastic Process	disease
TCMBANKDI015238		Musculoskeletal Diseases	-	Disease or Syndrome	disease
TCMBANKDI018716		Chemically-Induced Disorders; Mental Disorders	-	Mental or Behavioral Dysfunction	disease
TCMBANKDI023464		Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI028799		Eye Diseases	-	Disease or Syndrome	disease
TCMBANKDI031570		-	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease